BioCentury
ARTICLE | Clinical News

BIND-014: Phase II ongoing

February 8, 2016 8:00 AM UTC

Bind discontinued enrollment in the cholangiocarcinoma and bladder cancer cohorts of the open-label, international Phase II iNSITE 2 trial evaluating IV BIND-014 due to lower than anticipated enrollme...